Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum]
Hashimoto S, Ikeuchi H, Murata S, Kitawaki T, Ikeda K, Banerji D.Int J Chron Obstruct Pulmon Dis.2016;11:2543–2551. On page 2547, Hat Figure 5, x-axis, the dose mentioned in the label for IND should have read “150 μg od” instead of “110 μg od” and the dose for GLY should have read “50 μg od” i